ase) and anifrolumab (lupus) in the next 12 months. Related DB Research: Lynparza survey supports market leadership in potential >$7bn class; Buy (Parkes) Pharma: 2018 Outlook: Fundamentals solid but fewer debates than in prior years 1Parkesi Bull/bear case: limited downside, substantial upside poten

he US alone, many of whom have few effective treatments). Related DB Research: Shire: Headline HAVEN 3 data incrementally better than anticipated {Parkes( Pharma: 2018 Outlook: Fundamentals solid but fewer debates than in prior years (Parkest Bull/bear case: blue sky yields almost 45% upside 6000p 5

Ind ode. avalale cash balances, UBS Bank USA deposit account balances, UBS AG Starkrd Branch deposit account warms and money mates mut ud fund sweep Parkes. UBS Bank USA deposit account balances are Insured by the I cac Warm applicable limits, but are not protected by SIPC. UBS AG Stamford Branch depaa